A p.P30L MUTATION AT THE CYP21A2 GENE IN MACEDONIAN PATIENTS WITH NONCLASSICAL CONGENITAL ADRENAL HYPERPLASIA
Anastasovska V1, Kocova E1, Kocova M1,2,*
*Corresponding Author: Professor Dr. Mirjana Kocova, University Children’s Clinic, Department of Endocrinology and Genetics, Vodnjanska 17, 1000 Skopje, Macedonia; Tel.: +38-970-242-694; Fax: +38-923-176-167; E-mail: mirjanakocova@yahoo.com
page: 19

RESULTS AND DISCUSSION

Premature pubarche/adrenarche was present in six girls, hirsutism and oligoamenorrhea in two, and amenorrhea in one. The boys presented with adrenarche, typical development of genitalia, and increased rate of growth. Bone age was advanced by 3.6  1.2 years (range: 1 to 4.5). The peak of ACTH-stimulated 17OH-P serum level was higher than 60 nmol/L in all patients.

The p.P30L mutation was detected in all NCAH patients: seven patients (63.6%) were homozygous (five girls and two boys) and four girls (36.4%) were heterozygous. One of the heterozygous patients was also heterozygous for a p.Q318X mutation, as previously reported [14].

Patients with the p.P30L allele, although still categorized as nonclassical, tend to have pronounced evidence of androgen excess [16]. A genotype that contains two mild mutant alleles produces clinical symptoms of NCAH, the allele that produces most enzyme activity determining the phenotype [17,18]. Thus, the patient who was heterozygous for p.P30L and p.Q318X presented with a nonclassical phenotype. However, women who have NCAH may give birth to children with a classical form of the disease if the father is heterozygous for a severe mutation. Prenatal diagnosis in the case of such a combination of parents is strongly recommended. However, the correlation of genotype to phenotype that we found in all of our NCAH patients strengthens the concept that the genotype is predictive of phenotype.

Besides the p.P30L mutation which was derived from pseudogene, mutations not found in the pseudogene, p.R339H, p.P453S [19], and p.H62L [20,21] are also associated with partially impaired in vitro activity of 21-hydroxylase but together probably account for no more than 5% of NCAH alleles [22,23]. The p.P30L mutation was found in 11/17 of the family members (64.7%), 10 were heterozygotes (58.8%) and one was a homozygote (5.9%). Only the mother (homozygous for p.P30L) and father (homozygous for p.Q318X) of the compound heterozygous patient, as previously reported, had infertility and oligospermia, respectively [18].

The previously reported genetic analysis confirmed a significant genotype to phenotype correlation and a prevalence of NCAH of 1:7000 in the Macedonian population [24,25]. Although p.P30L is classified as a mild mutation in CYP21A2, its role in increased virilization remains to be elucidated.




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006